会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 148. 发明公开
    • 마이크로 RNA를 포함하는 조성물
    • 包含MICRORNA的组合物
    • KR1020120139430A
    • 2012-12-27
    • KR1020110059227
    • 2011-06-17
    • (주)아모레퍼시픽
    • 김규한신동욱이태룡심중현최현정
    • C12N15/113A61K31/7088A61Q19/00A61Q7/00
    • PURPOSE: A composition containing miRNA for controlling pigmentation gene expression is provided to suppress tyrosinase, tyrosinase-related proteins, and melan-A expression. CONSTITUTION: A composition for controlling pigmentation gene expression contains miRNA containing a base of sequence number 1 as an active ingredient. The miRNA has continuous 27 bases containing ccuucuu of sequence number 1 and a base which suppresses pigmentation gene expression. The pigmentation gene is tyrosinase, tyrosinase-related protein 1, or melan-A gene. The miRNA targets 909-915th nucleic acids of melan A mRNA 3'-UTR. The composition is a cosmetic or pharmaceutical composition for skin whitening. A composition for controlling pigmentation gene expression contains a complementary base with miRNA of sequence number 1. [Reference numerals] (AA) Relative TYR/GAPDH mRNA expression level; (BB) Comparative embodiment 1; (CC) Comparative embodiment 2; (DD) Embodiment 1
    • 目的:提供含有miRNA用于控制色素沉着基因表达的组合物,以抑制酪氨酸酶,酪氨酸酶相关蛋白和黑色素A表达。 构成:用于控制色素沉着基因表达的组合物含有含有序列号1的碱基作为活性成分的miRNA。 miRNA具有连续的27个碱基,其含有序列号1的碱基和抑制色素沉着基因表达的碱基。 色素沉着基因是酪氨酸酶,酪氨酸酶相关蛋白1或黑色素A基因。 miRNA靶向黑色A mRNA 3'-UTR的第909-915个核酸。 该组合物是用于皮肤美白的化妆品或药物组合物。 用于控制色素沉着基因表达的组合物含有与序列号1的miRNA的互补碱基。[参考数字](AA)相对TYR / GAPDH mRNA表达水平; (BB)比较实施例1; (CC)比较实施例2; (DD)实施例1
    • 150. 发明公开
    • 피부의 볼륨 증가 촉진용 조성물
    • 用于促进皮肤体积的组合物
    • KR1020120002964A
    • 2012-01-09
    • KR1020110137404
    • 2011-12-19
    • (주)아모레퍼시픽
    • 신동욱송민정노민수이형호이상민양승하김한곤
    • A61K36/49A61K36/898A61K36/537A61P17/00
    • A61K36/49A61K8/97A61K36/537A61K36/898A61Q19/08
    • PURPOSE: A composition for promoting differentiation of human mesenchymal stem cells into adipocytes is provided to enhance skin volume. CONSTITUTION: An external use skin composition for enhancing skin elasticity contains 0.0001-30 wt% of extract of Castaneae Semen, Selaginella tamariscina, Aloe vera L., Mentha arvensis var. piperascens Makinv., Pinellia ternata (Thunb.) Breit., Triticum aestivum L., Saururus chinensis Baill., Polygala tenuifolia Willd., or Gleditsia sinensis Lam. as an active ingredient. The composition promotes differentiation of mesenchymal stem cells into adipocytes. The mesenchymal stem cells are derived from human. A pharmaceutical composition for promoting differentiation of adipocytes contains the extract as an active ingredient.
    • 目的:提供用于促进人间充质干细胞分化为脂肪细胞的组合物,以增强皮肤体积。 构成:用于增强皮肤弹性的外用皮肤组合物含有0.0001-30重量%的蓖麻精,卷柏,芦荟提取物, (Piellens Makinv。),Pinellia ternata(Thunb。)Breit。,Triticum aestivum L.,Saururus chinensis Baill。,Polygala tenuifolia Willd。或Gleditsia sinensis Lam。 作为活性成分。 该组合物促进间充质干细胞分化为脂肪细胞。 间充质干细胞来源于人。 用于促进脂肪细胞分化的药物组合物含有提取物作为活性成分。